Leukemia
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Leukemia
Jun 26, 2024, 05:00 |
Blog
Lachelle Dawn: Fellows can join the Dana Farber’s division of Leukemia
Lachelle Dawn, Hematologist and Scientist at Dana-Farber Cancer Institute, shared on X: “I work with…
Jun 25, 2024, 06:17 |
Blog
Atrium Health Foundation's special guests who are helping to kick off the Keep Pounding 5K
Atrium Health Foundation shared on LinkedIn: "Meet our special guests, Travis and Cameron, who are…
Jun 23, 2024, 21:14 |
Blog
Raul Cordoba: How to make impact on hematology?
Raul Cordoba shared on X: "How to make impact on hematology? Discover it by joining…
Jun 20, 2024, 09:56 |
Blog
360° Model to address leukemia by Vuela Fundación
Childhood Cancer International shared on LinkedIn: "Vuela Fundación is a foundation originated in Mexico with…
Jun 19, 2024, 23:09 |
Blog
Wei Ying Jen: Very grateful to be standing on the shoulders of giants
Wei Ying Jen, Haematologist and Leukemia Doctor at MD Anderson Cancer Center, shared on X:…
Jun 19, 2024, 21:45 |
Insight
Fadi Haddad: Phase 1/2 trial of DSP-5336 menin inhibitor by Naval Daver
Fadi Haddad, Assistant Professor, Leukemia Department at MD Anderson Cancer Center, shared a post on X/Twitter:…
Jun 19, 2024, 12:19 |
Blog
Oncology Advance - See this month’s highlights from the ESMO portfolio
Oncology Advance shared a post on X: "See this month’s highlights from the ESMO portfolio. Featured…
Jun 19, 2024, 01:26 |
Blog
Ami Patel: An honor to work with Naveen Pemmaraju on MPN review article
Ami Patel, Hematologist at Huntsman Cancer Institute, shared a post by Naveen Pemmaraju on X, adding: “An…
Jun 18, 2024, 17:31 |
Insight
Amer Zeidan: Nothing is better than training international students on research
Amer Zeidan shared a post on X: “Nothing better training international students on research. True pleasure…
Jun 18, 2024, 10:27 |
Insight
Naveen Pemmaraju: Our brand new MPN state-of-the-art review paper
Naveen Pemmaraju shared on LinkedIn: . "Super excited to share our brand…
1
2
3
4
5
All:
82
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube